For patients who already have metabolic indications, shared decision-making is reasonable while monitoring weight, frailty and GI/pancreatobiliary risks. Advertisement "GLP1 agonists appear to have pleiotropic effects beyond diabetes and weight loss
Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis
Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Kber L, Petrie MC, McMurray JJV (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Journal Of The American Heart Association 2021, 10: e021084
Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao MS, Reddy JK
Sarah Meintel provides holistic wellness consultations to help pet owners explore integrative care options she does not administer, prescribe, or sell peptides through this platform
